Changing plasmid types responsible for extended-spectrum cephalosporin resistance in Escherichia coli O157:H7 in the USA, 1996-2009

Journal of Global Antimicrobial Resistance

Volumn 2, Issue 2, 2014, Pages 87-91

  Folster, J P ^a,b   Pecic, G ^a,b   Stroika, S ^a   Rickert, R ^a   Whichard, J M ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b Ihrc Inc   (United States)

Author keywords

Antimicrobial resistance; Cephalosporin resistance; Escherichia coli O157:H7; Resistance plasmid

Indexed keywords

BETA LACTAMASE; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; EXTENDED SPECTRUM CEPHALOSPORIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BIRD; CATTLE; ESCHERICHIA COLI O157; FOOD POISONING; MEAT; NONHUMAN; PLASMID; POULTRY; PRIORITY JOURNAL; SALMONELLA; UNITED STATES;

EID: 84901344794     PISSN: 22137165     EISSN: 22137173     Source Type: Journal    
DOI: 10.1016/j.jgar.2014.01.004     Document Type: Article

References (31)

1. W.A. Ferens, and C.J. Hovde Escherichia coli O157:H7: animal reservoir and sources of human infection Foodborne Pathog Dis 8 2011 465 487
2. M.E. Locking, S.J. O'Brien, W.J. Reilly, E.M. Wright, D.M. Campbell, and J.E. Coia et al. Risk factors for sporadic cases of Escherichia coli O157 infection: the importance of contact with animal excreta Epidemiol Infect 127 2001 215 220
3. L. Dipineto, A. Gargiulo, T.P. Russo, L.M. De Luca Bossa, L. Borrelli, and D. d'Ovidio et al. Survey of Escherichia coli O157 in captive frogs J Wildl Dis 46 2010 944 946
4. I. Feder, F.M. Wallace, J.T. Gray, P. Fratamico, P.J. Fedorka-Cray, and R.A. Pearce et al. Isolation of Escherichia coli O157:H7 from intact colon fecal samples of swine Emerg Infect Dis 9 2003 380 383
5. D.H. Rice, D.D. Hancock, and T.E. Besser Faecal culture of wild animals for Escherichia coli O157:H7 Vet Rec 152 2003 82 83
6. K.E. Smith, P.R. Wilker, P.L. Reiter, E.B. Hedican, J.B. Bender, and C.W. Hedberg Antibiotic treatment of Escherichia coli O157 infection and the risk of hemolytic uremic syndrome, Minnesota Pediatr Infect Dis J 31 2012 37 41
7. K. Ikeda, O. Ida, K. Kimoto, T. Takatorige, N. Nakanishi, and K. Tatara Effect of early fosfomycin treatment on prevention of hemolytic uremic syndrome accompanying Escherichia coli O157:H7 infection Clin Nephrol 52 1999 357 362
8. M. Shiomi, M. Togawa, K. Fujita, and R. Murata Effect of early oral fluoroquinolones in hemorrhagic colitis due to Escherichia coli O157:H7 Pediatr Int 41 1999 228 232
9. F. Artunc Treating Shiga toxin induced haemolytic uraemic syndrome BMJ 345 2012 e4598
10. W. Witte Medical consequences of antibiotic use in agriculture Science 279 1998 996 997
11. CMY-encoding plasmids among Salmonella isolated in the United States in 2007 Foodborne Pathog Dis 8 2011 1289 1294
12. A. Carattoli, A. Bertini, L. Villa, V. Falbo, K.L. Hopkins, and E.J. Threlfall Identification of plasmids by PCR-based replicon typing J Microbiol Methods 63 2005 219 228
13. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement. Document M100-S21 2011 CLSI Wayne, PA
14. US Centers for Disease Control and Prevention (CDC) National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS): enteric bacteria annual report, 2010 2010 US Department of Health and Human Services, CDC Atlanta, GA
15. P.L. Winokur, D.L. Vonstein, L.J. Hoffman, E.K. Uhlenhopp, and G.V. Doern Evidence for transfer of CMY-2 AmpC β-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals and humans Antimicrob Agents Chemother 45 2001 2716 2722
16. S. Corvec, N. Caroff, E. Espaze, J. Marraillac, and A. Reynaud -11 mutation in the ampC promoter increasing resistance to β-lactams in a clinical Escherichia coli strain Antimicrob Agents Chemother 46 2002 3265 3267
17. J. Kiiru, P. Butaye, B.M. Goddeeris, and S. Kariuki Analysis for prevalence and physical linkages amongst integrons, ISEcp1, ISCR1, Tn21 and Tn7 encountered in Escherichia coli strains from hospitalized and non-hospitalized patients in Kenya during a 19-year period (1992-2011) BMC Microbiol 13 2013 109
18. C. Mata, E. Miró, A. Alvarado, M.P. Garcillán-Barcia, M. Toleman, and T.R. Walsh et al. Plasmid typing and genetic context of AmpC β-lactamases in Enterobacteriaceae lacking inducible chromosomal ampC genes: findings from a Spanish hospital 1999-2007 J Antimicrob Chemother 67 2012 115 122
19. J.P. Folster, G. Pecic, S. Bolcen, L. Theobald, K. Hise, and A. Carattoli et al. Characterization of extended-spectrum cephalosporin-resistant Salmonella enterica serovar Heidelberg isolated from humans in the United States Foodborne PathogDis 7 2010 181 187
20. A. García-Fernández, G. Chiaretto, A. Bertini, L. Villa, D. Fortini, and A. Ricci et al. Multilocus sequence typing of IncI1 plasmids carrying extended-spectrum β-lactamases in Escherichia coli and Salmonella of human and animal origin J Antimicrob Chemother 61 2008 1229 1233
21. L. Martínez-Martínez, A. Pascual, and G.A. Jacoby Quinolone resistance from a transferable plasmid Lancet 351 1998 797 799
22. F.L. Macrina, D.J. Kopecko, K.R. Jones, D.J. Ayers, and S.M. McCowen A multiple plasmid-containing Escherichia coli strain: convenient source of size reference plasmid molecules Plasmid 1 1978 417 420
23. E.M. Ribot, M.A. Fair, R. Gautom, D.N. Cameron, S.B. Hunter, and B. Swaminathan et al. Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet Foodborne Pathog Dis 3 2006 59 67
24. J.M. Whichard, K. Joyce, P.D. Fey, J.M. Nelson, F.J. Angulo, and T.J. Barrett β-Lactam resistance and Enterobacteriaceae, United States Emerg Infect Dis 11 2005 1464 1466
25. World Health Organization Critically important antimicrobials for human medicine 2nd rev. 2009 WHO Geneva, Switzerland
26. P.J. Baudry, L. Mataseje, G.G. Zhanel, D.J. Hoban, and M.R. Mulvey Characterization of plasmids encoding CMY-2 AmpC β-lactamases from Escherichia coli in Canadian intensive care units Diagn Microbiol Infect Dis 65 2009 379 383
27. K.L. Hopkins, E. Liebana, L. Villa, M. Batchelor, E.J. Threlfall, and A. Carattoli Replicon typing of plasmids carrying CTX-M or CMY β-lactamases circulating among Salmonella and Escherichia coli isolates Antimicrob Agents Chemother 50 2006 3203 3206
28. T.J. Welch, W.F. Fricke, P.F. McDermott, D.G. White, M.L. Rosso, and D.A. Rasko et al. Multiple antimicrobial resistance in plague: an emerging public health risk PLoS ONE 2 2007 e309
29. S.R. Kim, and T. Komano The plasmid R64 thin pilus identified as a type IV pilus J Bacteriol 179 1997 3594 3603
30. K.A. Jolley, and M.C. Maiden BIGSdb: scalable analysis of bacterial genome variation at the population level BMC Bioinform 11 2010 595
31. L.F. Mataseje, P.J. Baudry, G.G. Zhanel, D.W. Morck, R.R. Read, and M. Louie et al. Comparison of CMY-2 plasmids isolated from human, animal, and environmental Escherichia coli and Salmonella spp., from Canada Diagn MicrobiolInfect Dis 67 2010 387 391